Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. Ann Neurol. 2009 Oct; 66(4):513-20.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.